(Q43227264)

16 November 2017

title

On the role of glucose-dependent insulintropic polypeptide in postprandial metabolism in humans (English)

1 reference

16 November 2017

3

1 reference

16 November 2017

5

1 reference

16 November 2017

8

1 reference

16 November 2017

Jens Bülow

7

0 references

Meena Asmar

series ordinal

1

object named as

Meena Asmar

1 reference

16 November 2017

Winnie Tangaa

2

1 reference

16 November 2017

Kristine Hare

series ordinal

4

1 reference

16 November 2017

Anne Flint

series ordinal

6

1 reference

16 November 2017

publication date

8 December 2009

1 reference

American Journal of Physiology - Endocrinology and Metabolism

16 November 2017

published in

1 reference

16 November 2017

volume

298

1 reference

16 November 2017

issue

3

1 reference

16 November 2017

page(s)

E614-21

1 reference

Effects of the phases of the menstrual cycle on gastric emptying, glycemia, plasma GLP-1 and insulin, and energy intake in healthy lean women.

16 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00639.2009

Effects of peripheral administration of synthetic human glucose-dependent insulinotropic peptide (GIP) on energy expenditure and subjective appetite sensations in healthy normal weight subjects and obese patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00639.2009

Effect of Exogenous or Endogenous Gastric Inhibitory Polypeptide (GIP) on Plasma Triglyceride Responses in Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00639.2009

The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00639.2009

Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00639.2009

The combined effects of exercise and food intake on adipose tissue and splanchnic metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00639.2009

Gastric Inhibitory Polypeptide (GIP) Stimulated by Fat Ingestion in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00639.2009

An automated method for the measurement of oxygen consumption and carbon dioxide excretion in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00639.2009

Dorothy Hodgkin Lecture 2008. Gastric inhibitory polypeptide (GIP) revisited: a new therapeutic target for obesity-diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00639.2009

Plasma immunoreactive gastric inhibitory polypeptide in obese hyperglycaemic (ob/ob) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00639.2009

Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00639.2009

Gastric inhibitory polypeptide does not inhibit gastric emptying in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00639.2009

Inhibition of gastric inhibitory polypeptide signaling prevents obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00639.2009

The Insulinotropic Action of Gastric Inhibitory Polypeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00639.2009

Gastric emptying and release of incretin hormones after glucose ingestion in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00639.2009

Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00639.2009

Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00639.2009

Effect of gastric inhibitory polypeptide on plasma levels of chylomicron triglycerides in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00639.2009

Use of oral and intravenous fat tolerance tests to assess plasma chylomicron clearance in dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00639.2009

Structure, measurement, and secretion of human glucagon-like peptide-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00639.2009

Secretory effects of gastric inhibitory polypeptide on the isolated perfused porcine pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00639.2009

10.1152/AJPENDO.00639.2009

21 January 2018

Identifiers

DOI

1 reference

16 November 2017

1 reference